» Articles » PMID: 22311906

Aldosterone Blunts Tubuloglomerular Feedback by Activating Macula Densa Mineralocorticoid Receptors

Overview
Journal Hypertension
Date 2012 Feb 8
PMID 22311906
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic aldosterone administration increases glomerular filtration rate, whereas inhibition of mineralocorticoid receptors (MRs) markedly attenuates glomerular hyperfiltration and hypertension associated with primary aldosteronism or obesity. However, the mechanisms by which aldosterone alters glomerular filtration rate regulation are poorly understood. In the present study, we hypothesized that aldosterone suppresses tubuloglomerular feedback (TGF) via activation of macula densa MR. First, we observed the expression of MR in macula densa cells isolated by laser capture microdissection and by immunofluorescence in rat kidneys. Second, to investigate the effects of aldosterone on TGF in vitro, we microdissected the juxtaglomerular apparatus from rabbit kidneys and perfused the afferent arteriole and distal tubule simultaneously. Under control conditions, TGF was 2.8±0.2 μm. In the presence of aldosterone (10(-8) mol/L), TGF was reduced by 50%. The effect of aldosterone to attenuate TGF was blocked by the MR antagonist eplerenone (10(-5) mol/L). Third, to investigate the effect of aldosterone on TGF in vivo, we performed micropuncture, and TGF was determined by maximal changes in stop-flow pressure P(sf) when tubular perfusion rate was increased from 0 to 40 nL/min. Aldosterone (10(-7) mol/L) decreased ΔP(sf) from 10.1±1.4 to 7.7±1.2 mm Hg. In the presence of l-NG-monomethyl arginine citrate (10(-3) mol/L), this effect was blocked. We conclude that MRs are expressed in macula densa cells and can be activated by aldosterone, which increases nitric oxide production in the macula densa and blunts the TGF response.

Citing Articles

No "U-shaped" associations of estimated glomerular filtration rate with adverse cardiovascular outcomes in patients with primary aldosteronism.

Yoshida Y, Shibata H Hypertens Res. 2023; 47(1):247-249.

PMID: 37945892 DOI: 10.1038/s41440-023-01506-5.


Kidney function predicts new-onset cardiorenal events and mortality in primary aldosteronism: approach of the 2021 race-free eGFR equation.

Lai C, Lin Y, Huang K, Chueh J, Wu V Hypertens Res. 2023; 47(1):233-244.

PMID: 37714953 DOI: 10.1038/s41440-023-01400-0.


Obesity-related glomerulopathy in children: connecting pathophysiology to clinical care.

Mangat G, Nair N, Barat O, Abboud B, Pais P, Bagga S Clin Kidney J. 2023; 16(4):611-618.

PMID: 37007691 PMC: 10061436. DOI: 10.1093/ckj/sfac233.


Markers of Kidney Tubular Function Deteriorate While Those of Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments.

Wu V, Chan C, Chueh J, Chen Y, Lin Y, Chang C J Am Heart Assoc. 2023; 12(4):e028146.

PMID: 36789834 PMC: 10111488. DOI: 10.1161/JAHA.122.028146.


Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury.

Nakamura T, Bonnard B, Palacios-Ramirez R, Fernandez-Celis A, Jaisser F, Lopez-Andres N Int J Mol Sci. 2022; 23(12).

PMID: 35743123 PMC: 9224513. DOI: 10.3390/ijms23126680.


References
1.
Oberleithner H, Kersting U, Silbernagl S, Steigner W, Vogel U . Fusion of cultured dog kidney (MDCK) cells: II. Relationship between cell pH and K+ conductance in response to aldosterone. J Membr Biol. 1989; 111(1):49-56. DOI: 10.1007/BF01869208. View

2.
Rad A, Balment R, Ashton N . Rapid natriuretic action of aldosterone in the rat. J Appl Physiol (1985). 2004; 98(2):423-8. DOI: 10.1152/japplphysiol.00572.2004. View

3.
Ribstein J, Cailar G, Fesler P, Mimran A . Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol. 2005; 16(5):1320-5. DOI: 10.1681/ASN.2004100878. View

4.
Gomez-Sanchez C, de Rodriguez A, Romero D, Estess J, Warden M, Gomez-Sanchez M . Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology. 2005; 147(3):1343-8. DOI: 10.1210/en.2005-0860. View

5.
Schnermann J, Smart A, Killen P, Briggs J . Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron. Am J Physiol. 1993; 264(5 Pt 2):F781-91. DOI: 10.1152/ajprenal.1993.264.5.F781. View